trending Market Intelligence /marketintelligence/en/news-insights/trending/lixbev5j_p3n7_kexkkwaq2 content esgSubNav
In This List

Adverum Biotechnologies starts common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Adverum Biotechnologies starts common stock offering

Adverum Biotechnologies Inc. initiated an underwritten public offering of its common shares.

The company also plans to grant the underwriters an option to buy up to an additional 15% of the common shares.

Cowen and Piper Jaffray & Co. are acting as joint book-running managers and Raymond James is acting as lead manager for the proposed offering.